Highlights
New Technology
A new skin rejuvenation technology, called Plasma Skin Resurfacing, was introduced in February 2005. The technology uses plasma energy to rejuvenate the skin from the deeper layers outwards. The energy is released by using radio waves on nitrogen gas. According to the manufacturer, skin regeneration is rapid, and satisfaction with the procedure appears high. Long-term follow-up studies are not available yet for this new method.
Drug Research
Dimeracin, a new cream under investigation in clinical studies, can repair sun-related DNA damage in skin cells. The cream shows significant benefits in reducing rates of non-melanoma skin cancer in people with a genetic risk for these cancers. The drug manufacturer hopes to find a way to incorporate this cream into sunscreens.
Facial Filler Approval
The U.S. Food and Drug Administration (FDA) has approved the Juvéderm product line for treatment of moderate-to-severe facial wrinkles and folds. Juvéderm products are gels made from hyaluronic acid. They are injected into the face.
New Drug Approval
FDA has approved Anthelios SX, a new sunscreen that prevents sunburn and protects against ultraviolet A and B rays. The product contains ecamsule, an ingredient used in sunscreens in Europe for years but not previously marketed in the United States. FDA advises consumers, in addition to using a sunscreen, to limit time in the sun and wear protective clothing to help diminish sun exposure.
